Raptor buys into cystic fibrosis with a $418M deal

Damian Garde

Rare disease biotech Pharmaceutical signed a to pay up to $ 418 million to Tripex Pharmaceuticals in exchange for an inhaled treatment for .

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS